Registry for Endoscopic Bariatric Therapies

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects data on the efficacy and safety of various endoscopic bariatric therapies (EBTs) through medical chart reviews and patient visits. It includes both retrospective and prospective data collection over a period of up to one year following patient consent. The study aims to evaluate how well EBTs perform compared to other weight loss treatments for patients who are not candidates for traditional bariatric surgery. Information gathered will include laboratory data, patient characteristics, and imaging results.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Any patient who is considering undergoing EBT for weight loss within 6 months, or has undergone clinically indicated EBT for weight loss within the past 6 months
* Above or equal to 18 years of age.

Exclusion Criteria:

* Any patient who has not undergone or will undergo EBT for weight loss
* Below 18 years of age.

Where it's running

• Weill Cornell Medicine
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Reem Z Sharaiha, MD — Weill Medical College of Cornell University
• Study coordinator: Reem Z Sharaiha, MD, MSc.
• Email: rzs9001@med.cornell.edu
• Phone: 646-962-2382

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Stress response with desflurane versus opioid-free TIVA during weight-loss surgery

  This study will test whether adding the inhaled anesthetic desflurane to opioid-free anesthesia changes the body's perioperative stress response in people having bariatric (weight-loss) surgery.

  Recruiting G.Gennimatas General Hospital · Athens · NCT07568938

• Fasted versus fed aerobic exercise for weight loss and heart health

  This 16-week program will see if doing aerobic exercise before breakfast (fasted) versus after eating helps adults with overweight or obesity lose more weight and improve heart-related measures.

  Recruiting Phase 2 Arkansas Colleges of Health Education · Fort Smith, Arkansas · NCT07487090

• Personalized weight-loss medication plan for adults with bipolar disorder

  This pilot tests whether matching FDA-approved weight-loss medicines to specific obesity types helps adults aged 18–65 with bipolar disorder lose weight.

  Recruiting Phase 4 Mayo Clinic · Rochester, Minnesota · NCT07213466

• Efsubaglutide alfa for weight loss after metabolic surgery

  This trial will test whether efsubaglutide alfa helps people who remain obese six months after metabolic surgery lose weight and improve obesity-related health problems.

  Recruiting Phase 4 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu · NCT07163650

• Family COMIDA — helping Hispanic families choose healthier foods to prevent and reduce obesity

  This program tests family-centered support (parent counseling, weekly phone coaching, monthly group sessions, and child education) to help Hispanic parents/caregivers and their 8–12-year-old children prevent or reduce obesity.

  Recruiting Memorial Sloan Kettering Cancer Center · New York, New York · NCT07144800

• Protein supplements with semaglutide and a calorie-restricted diet for weight loss

  This will test whether adding daily protein supplements to semaglutide plus a calorie-restricted diet helps adults with overweight or obesity lose more weight, preserve muscle, and reduce weight regain.

  Recruiting Chinese Academy of Sciences · Hangzhou, Zhejiang · NCT06989203

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.